Global Wealth Management Investment Advisory’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-633
Closed -$18.2K 349
2023
Q4
$18.2K Sell
633
-75,922
-99% -$2.3M ﹤0.01% 257
2023
Q3
$2.54M Buy
76,555
+6,956
+10% +$246K 0.71% 50
2023
Q2
$2.55M Buy
69,599
+1,509
+2% +$58.7K 0.7% 51
2023
Q1
$2.78M Buy
68,090
+2,512
+4% +$108K 0.84% 46
2022
Q4
$3.36M Buy
65,578
+19,545
+42% +$937K 1.09% 32
2022
Q3
$2.01M Buy
46,033
+1,645
+4% +$79.9K 0.72% 52
2022
Q2
$2.33M Buy
44,388
+3,019
+7% +$154K 0.78% 46
2022
Q1
$2.14M Sell
41,369
-4,048
-9% -$210K 0.64% 57
2021
Q4
$2.68M Buy
45,417
+501
+1% +$24.8K 0.81% 46
2021
Q3
$1.93M Sell
44,916
-846
-2% -$37.5K 0.61% 58
2021
Q2
$1.79M Buy
45,762
+1,616
+4% +$62.8K 0.6% 61
2021
Q1
$1.6M Sell
44,146
-19,702
-31% -$700K 0.58% 64
2020
Q4
$2.35M Sell
63,848
-1,000
-2% -$36.7K 0.91% 36
2020
Q3
$2.26M Buy
64,848
+668
+1% +$23.4K 0.98% 32
2020
Q2
$1.99M Buy
64,180
+1,781
+3% +$60.5K 0.85% 41
2020
Q1
$1.93M Buy
62,399
+5,010
+9% +$171K 0.97% 34
2019
Q4
$2.13M Buy
57,389
+7,671
+15% +$273K 0.9% 36
2019
Q3
$1.7M Buy
49,718
+4,677
+10% +$170K 0.78% 53
2019
Q2
$1.85M Buy
45,041
+6,314
+16% +$251K 0.9% 39
2019
Q1
$1.56M Buy
38,727
+34,670
+855% +$1.39M 0.81% 46
2018
Q4
$168K Buy
+4,057
New +$168K 0.1% 141

Other funds holding PFE

Global Wealth Management Investment Advisory's PFE Position: Q1 2024 in Review

Global Wealth Management Investment Advisory sold out of Pfizer (PFE) in Q1 2024, closing a stake of 633 shares — an estimated $18.2K sold.

Global Wealth Management Investment Advisory first reported a position in PFE in Q4 2018 and held it in 21 quarters. The position peaked at $3.36M in Q4 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Global Wealth Management Investment Advisory reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 633 Pfizer shares in Q1 2024, an estimated $18.2K.
  • Global Wealth Management Investment Advisory first reported a position in Pfizer in Q4 2018 and held it in 21 quarters.
  • Global Wealth Management Investment Advisory's Pfizer position peaked at $3.36M in Q4 2022.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Global Wealth Management Investment Advisory's 13F filing for Q1 2024, filed 10 May 2024.